Sort
16,300 grants matching “fatty liver disease”
Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism
$491,460Qin Yang · University Of California-Irvine · R01 · FY2023 · DK
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis
$491,425John Daniel Clarke · Washington State University · R01 · FY2022 · ES
Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease
$491,417Shuxia Wang · University Of Kentucky · R01 · FY2022 · DK
The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity
$491,351David George Ashbrook · University Of Tennessee Health Sci Ctr · R01 · FY2022 · AG
Growth Hormone Regulation of Sex Differences in Liver Metabolism
$491,118David J Waxman · Boston University (Charles River Campus) · R01 · FY2019 · DK
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.
$491,106Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2025 · CA
Hormonal Regulation of Fat Deposition
$491,029Jonathan M Graff · Ut Southwestern Medical Center · R01 · FY2014 · DK
'Metabolically Activated' Macrophages in Obesity and Insulin Resistance
$490,784Lev Becker · University Of Chicago · R01 · FY2024 · DK
Translational Systems Genetics of Mitochondria, Metabolism, and Aging
$490,637Robert W. W Williams · University Of Tennessee Health Sci Ctr · R01 · FY2015 · AG
Brain endoplasmic reticulum stress in non-alcoholic fatty liver disease
$490,589Colin Neal Young · George Washington University · R01 · FY2020 · DK
Macrophage Functional Response in Hemolytic Complications
$490,524Francesca Vinchi · New York Blood Center · P01 · FY2020 · HL
Macrophage Functional Response in Hemolytic Complications
$490,524Francesca Vinchi · New York Blood Center · P01 · FY2022 · HL
Macrophage Functional Response in Hemolytic Complications
$490,524Francesca Vinchi · New York Blood Center · P01 · FY2023 · HL
Macrophage Functional Response in Hemolytic Complications
$490,524Francesca Vinchi · New York Blood Center · P01 · FY2021 · HL
Hormonal Regulation of Fat Deposition
$490,513Jonathan M Graff · Ut Southwestern Medical Center · R01 · FY2012 · DK
Host-microbiome interactions shape the metabolic effects of ketogenic diets
$490,405Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2024 · DK
Molecular Prognostic Indicators in Liver Cirrhosis and Cancer
$490,399Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · DK
Multiscale Analysis of Inter-Clock Communication
$490,386John B Hogenesch · University Of Pennsylvania · R01 · FY2012 · HL
Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion
$490,258Gregory A Graf · University Of Kentucky · R01 · FY2023 · DK
Biomarkers of Metabolic and Vascular Risk in Obesity
$490,199Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2009 · DK
Role of lncRNA Meg3 in obesity-induced endothelial senescence and insulin resistance
$490,183Xinghui Sun · University Of Nebraska Lincoln · R01 · FY2022 · HL
Identification of metabolic regulators of glycerolipid synthesis and storage
$490,172Kivanc Birsoy · Rockefeller University · R01 · FY2022 · DK
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$490,162Carol A Casey · University Of Nebraska Medical Center · R01 · FY2015 · AA
Pharmaceutical Sciences and Pharmacogenomics
$490,150Su Guo · University Of California, San Francisco · T32 · FY2025 · GM
Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis
$490,061Anna Mae Elizabeth Diehl · Duke University · U01 · FY2022 · DK